Welcome to LookChem.com Sign In|Join Free

CAS

  • or

59-02-9

Post Buying Request

59-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • High Quality 99% 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-,[2R-[2R*(4R*,8R*)]]- 59-02-9 ISO Producer

    Cas No: 59-02-9

  • USD $ 0.1-0.1 / Gram

  • 1 Gram

  • 100 Metric Ton/Year

  • Xi'an Xszo Chem Co., Ltd.
  • Contact Supplier

59-02-9 Usage

Chemical Properties

Different sources of media describe the Chemical Properties of 59-02-9 differently. You can refer to the following data:
1. light yellow liquid
2. VITAMIN E is sometimes referred to as the antisterility vitamin, factor X (an earlier designation), chemically vitamin E is alphatocopherol. Active analogues and related compounds include: dl-α-Tocopherol; 1-α-tocopherol; esters (succinate, acetate, phosphate), and β, ζ 1, ζ 2- tocopherols. The principal physiological forms are D-a-tocopherol, tocopheronolactone, and their phosphate esters.

Originator

Doppelherz,Queisser Pharma,Germany

Uses

Different sources of media describe the Uses of 59-02-9 differently. You can refer to the following data:
1. vitamin E, antioxidant
2. α-Tocopherol is the most bioactive of the naturally occurring forms of Vitamin E. Richest sources are green vegetables, grains, and oils, particularly palm, safflower and sunflower oils.
3. Use in insect cell culture applications as an antioxidant.

Definition

ChEBI: An alpha-tocopherol that has R,R,R configuration. The naturally occurring stereoisomer of alpha-tocopherol, it is found particularly in sunflower and olive oils.

Manufacturing Process

Manufacturing process for Vitamin E, that is, α-tocopherol (5,7,8-trimethyltocol) in the past has been accomplished primarily by reacting trimethylhydroquinone (TMHQ) with isophytol (3,7,11,15-tetramethylhexadec-1-en-3-ol) or phytol (3,7,11,15-tetramethylhexadec-2-en-1-ol) in a condensation reaction. The reaction is well known and has been practiced for many years (StallaBourdillon, Ind. Chim. Belg., 35, 13 (1970); "The Vitamins" Vol. 5, pages 168- 223, Academic Press, New York, 1967). The Synthesis of Vitamin E includes these steps as follows: Rearrangement to C15 Acetylene; Saponification of the C20 Dienol Acetate to Dehydrophytol;Condensation of Dehydrophytol with TMHQ to yield Dehydro-Vitamin E.

Therapeutic Function

Antioxidant

General Description

α-Tocopherol is synthesized from γ-tocopherol by the action of enzyme γ-tocopherol methyltransferase. It is the major form of Vitamin E in human plasma. It is present in sunflower seed oil.

Health Hazard

The physiological functions of vitamin E substances include: (1) bio logical antioxidant; (2) normal growth maintenance; (3) protects unsaturated fatty acids and membrane structures; (4) aids intestinal absorption of unsaturated fatty acids; (5) maintains normal muscle metabolism; (6) maintains integrity of vascular system and central nervous system; (7) detoxifying agent; and (8) maintains kidney tubules, lungs, genital structures, liver, and red blood cell membranes.In livestock and laboratory animals, a deficiency of vitamin E substances may cause degeneration of reproductive tissues, muscular dystrophy, encephalomalacia, and liver necrosis. Considerable research is required to fully determine supplementation of livestock diets unless typical symptoms of a deficiency appear. Symptoms have appeared where there are selenium deficiencies in the soil and where there are excessive levels of nitrates in the soil. “White muscle” is the term used to describe a condition of muscular dystrophy in cattle.

Biochem/physiol Actions

α-Tocopherol is essential for the photosynthesis in Synechocystis sp. strain PCC 6803. Supplementation with α-Tocopherol decreases lipid peroxidation and platelet aggregation. It inhibits protein kinase C and may play key role in gene regulation.

Safety Profile

Experimental reproductive effects. Mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.

Purification Methods

Vitamin E is a viscous yellow oil which is distilled at high vacuum. It has max at 294nm (E1cm 1% 71). It is oxygen and light sensitive and is best stored as its stable D--acetate [58-95-7] which is purified by evaporative distillation at b 180-200o(bath temperature)/0.7mm, and has [] D 25 +3.3o (c 5.1, EtOH). It forms needles at -30o and has m 26.5-27.5o, [] D 25 +0.25o (c 10, CHCl3). [NMR: Cohen et al. Helv Chim Acta 6 4 1158 1981, Burton & Ingold Acc Chem Res 1 9 194 1986, Karrer et al. Helv Chim Acta 2 1 520 1938, Robeson J Am Chem Soc, 64 1487 1942, 65 1660 1943.] Of the eight isomers the D--isomer is the most active. [See W. Friedrich “Vitamins” Walter de Guyter Publ, Berlin 1988.] [Beilstein 17/4 V 168.]

Check Digit Verification of cas no

The CAS Registry Mumber 59-02-9 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 59-02:
(4*5)+(3*9)+(2*0)+(1*2)=49
49 % 10 = 9
So 59-02-9 is a valid CAS Registry Number.

59-02-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T2309)  D-α-Tocopherol  >97.0%(GC)

  • 59-02-9

  • 25g

  • 395.00CNY

  • Detail
  • Sigma

  • (T1539)  (+)-α-Tocopherol  Type VI, from vegetable oil, neat (liquid, ≥0.88M based on potency, density and molecular wt.), BioReagent, suitable for insect cell culture, ≥1000 IU/g

  • 59-02-9

  • T1539-25G

  • 422.37CNY

  • Detail
  • Sigma

  • (T1539)  (+)-α-Tocopherol  Type VI, from vegetable oil, neat (liquid, ≥0.88M based on potency, density and molecular wt.), BioReagent, suitable for insect cell culture, ≥1000 IU/g

  • 59-02-9

  • T1539-100G

  • 1,282.32CNY

  • Detail
  • Sigma

  • (T3634)  (+)-α-Tocopherol  from vegetable oil, Type V, ~1000 IU/g

  • 59-02-9

  • T3634-10G

  • 154.44CNY

  • Detail
  • Sigma

  • (T3634)  (+)-α-Tocopherol  from vegetable oil, Type V, ~1000 IU/g

  • 59-02-9

  • T3634-25G

  • 269.10CNY

  • Detail
  • Sigma

  • (T3634)  (+)-α-Tocopherol  from vegetable oil, Type V, ~1000 IU/g

  • 59-02-9

  • T3634-100G

  • 989.82CNY

  • Detail

59-02-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (+)-α-tocopherol

1.2 Other means of identification

Product number -
Other names (+)-α-Tocopherol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59-02-9 SDS

59-02-9Synthetic route

titanium montmorillonite

titanium montmorillonite

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
In octane100%
(2R,4'R,8'R)-α-tocopheryl methyl ether
32466-45-8

(2R,4'R,8'R)-α-tocopheryl methyl ether

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
Stage #1: (2R,4'R,8'R)-α-tocopheryl methyl ether With triethylsilane; tris(pentafluorophenyl)borate at 20℃;
Stage #2: With tetrabutyl ammonium fluoride In tetrahydrofuran at 0℃;
100%
With aluminum (III) chloride; boron dimethyl-trifluoro sulphide In dichloromethane; acetonitrile at 20℃;84%
With aluminum (III) chloride; boron trifluoride dimethyl sulfide In dichloromethane; acetonitrile at 0 - 20℃; for 6h;78%
isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With hydrogenchloride; Zinc chloride In tetrachloromethane99.1%
With hydrogenchloride; sodium dithionite; Zinc chloride In toluene99.8%
With hydrogenchloride; zinc dibromide; zinc98.6%
2-methylpropyl acetate
110-19-0

2-methylpropyl acetate

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With hydrogenchloride; Zinc chloride In water; toluene99.6%
With hydrogenchloride; Zinc chloride In water; toluene98.6%
isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Diethyl carbonate
105-58-8

Diethyl carbonate

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With hydrogenchloride; sodium chloride; Zinc chloride In water; toluene99.2%
With hydrogen bromide; zinc dibromide In water99.1%
With hydrogenchloride; Zinc chloride In water; toluene98.9%
isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

butanone
78-93-3

butanone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium hydroxide; sodium chloride; scandium tris(trifluoromethanesulfonate) In ethyl acetate; toluene99%
isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

butan-1-ol
71-36-3

butan-1-ol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With hydrogenchloride; Zinc chloride In hexane; water; toluene98.1%
With hydrogenchloride; Zinc chloride In hexane; water; toluene98.1%
With hydrogenchloride; Zinc chloride In hexane; water; toluene95.9%
With hydrogenchloride; Zinc chloride In hexane; water; toluene95.9%
Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

isophytol

isophytol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
aluminum ion-exchanged montmorilonites In octane for 3h; Product distribution; Heating; var. metal ion-exchanged montmorilonites, var. solvents, var. reaction time;98%
scandium fluorosulfonate

scandium fluorosulfonate

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium chloride In ethyl acetate; toluene98%
2-((7R,11R)-3-Hydroxy-3,7,11,15-tetramethylhexadecyl)-3,5,6-trimethylbenzene-1,4-diol
14745-36-9

2-((7R,11R)-3-Hydroxy-3,7,11,15-tetramethylhexadecyl)-3,5,6-trimethylbenzene-1,4-diol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene at 80℃; for 1.25h;95%
With toluene-4-sulfonic acid In benzene Heating;
With toluene-4-sulfonic acid In toluene at 45℃;
(2R,4'R,8'R)-5-(morpholinomethyl)-γ-tocopherol
6991-51-1

(2R,4'R,8'R)-5-(morpholinomethyl)-γ-tocopherol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium hydroxide; sodium tetrahydroborate In 2-methyl-propan-1-ol for 9h; Heating;95%
scandium bentonite

scandium bentonite

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
In hexane; toluene93%
4-methoxybenzyl (R,R,R)-α-tocopheryl ether
1402580-98-6

4-methoxybenzyl (R,R,R)-α-tocopheryl ether

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With silver hexafluoroantimonate; 1,2,3-trimethoxybenzene In dichloromethane at 40℃; for 6h;93%
isophytol
505-32-8

isophytol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
In toluene91%
88.7%
2-[(3R,7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dione
7559-04-8

2-[(3R,7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dione

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
90.3%
(2R,4'R,8'R)-1',2'-dehydro-α-tocopheryl benzyl ether

(2R,4'R,8'R)-1',2'-dehydro-α-tocopheryl benzyl ether

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With hydrogen; palladium dihydroxide at 20℃; under 760 Torr;86%
europium trifluoromethanesulfonate

europium trifluoromethanesulfonate

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium chloride In 5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; ethyl acetate84%
isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

yttrium(III) trifluoromethanesulfonate

yttrium(III) trifluoromethanesulfonate

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium chloride In diethyl ether; nitromethane; ethyl acetate82%
(2R,4'R,8'R)-5-(morpholinomethyl)-γ-tocopherol
6991-51-1

(2R,4'R,8'R)-5-(morpholinomethyl)-γ-tocopherol

tetrabutylammonium borohydride

tetrabutylammonium borohydride

A

n-butyl α-tocopheryl ether

n-butyl α-tocopheryl ether

B

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
In 2-methyl-propan-1-ol for 4h; Heating;A n/a
B 77%
6-hydroxy-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)chroman-5-carbaldehyde
113348-75-7

6-hydroxy-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)chroman-5-carbaldehyde

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In acetic acid under 760 Torr;75%
(2R,6R)-1-chloro-2,6,10-trimethyl-undecane

(2R,6R)-1-chloro-2,6,10-trimethyl-undecane

dilithium tetrachlorocuprate

dilithium tetrachlorocuprate

(2R,6R)-2,6,10-trimethyl-1-undecyl-magnesium chloride

(2R,6R)-2,6,10-trimethyl-1-undecyl-magnesium chloride

methylmagnesium bromide
75-16-1

methylmagnesium bromide

(2S)-(-)-2-(2-bromoethyl)-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol
94353-04-5

(2S)-(-)-2-(2-bromoethyl)-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
In tetrahydrofuran75%
Durohydroquinone
527-18-4

Durohydroquinone

2-methylbut-3-en-2-ol

2-methylbut-3-en-2-ol

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
Molecular sieve;72%
(2RS,6RS)-2,6,10-trimethyl-1-undecylmagnesium chloride

(2RS,6RS)-2,6,10-trimethyl-1-undecylmagnesium chloride

(2RS,6RS)-1-chloro-2,6,10-trimethylundecane

(2RS,6RS)-1-chloro-2,6,10-trimethylundecane

dilithium tetrachlorocuprate

dilithium tetrachlorocuprate

methylmagnesium bromide
75-16-1

methylmagnesium bromide

2-(2-bromoethyl)-3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran
130266-62-5

2-(2-bromoethyl)-3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
In tetrahydrofuran64%
scandium(III) nitrate

scandium(III) nitrate

scandium(III) nitrate tetrahydrate

scandium(III) nitrate tetrahydrate

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium chloride In ethyl acetate; toluene62%
Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

2-methylbut-3-en-2-ol

2-methylbut-3-en-2-ol

A

trimethyl-((7R:11R)-trans-phytyl)-benzoquinone-(1.4)
151716-51-7

trimethyl-((7R:11R)-trans-phytyl)-benzoquinone-(1.4)

B

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With CuAl-SBA-15 In cyclohexane at 85℃; for 16h;A 25%
B 61%
ytterbium trifluoromethanesulfonate

ytterbium trifluoromethanesulfonate

isophytol
505-32-8

isophytol

Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

Tocopherol
59-02-9

Tocopherol

Conditions
ConditionsYield
With sodium chloride In 5,5-dimethyl-1,3-cyclohexadiene; ethyl acetate59%
hexaethylphosphoric triamide
2283-11-6

hexaethylphosphoric triamide

Tocopherol
59-02-9

Tocopherol

bis(N,N-diethylamido)-O-tocopherylphosphite
562828-32-4

bis(N,N-diethylamido)-O-tocopherylphosphite

Conditions
ConditionsYield
at 90 - 100℃; for 5h;100%
1,4-dibromo-butane
110-52-1

1,4-dibromo-butane

Tocopherol
59-02-9

Tocopherol

(R)-6-(4-bromobutoxy)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman
1451385-71-9

(R)-6-(4-bromobutoxy)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium hydroxide In tetrahydrofuran; water at 0 - 20℃; Inert atmosphere; Darkness;100%
Stage #1: Tocopherol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h; Inert atmosphere;
Stage #2: 1,4-dibromo-butane In N,N-dimethyl-formamide at 20℃; Inert atmosphere;
50%
Stage #1: Tocopherol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: 1,4-dibromo-butane In N,N-dimethyl-formamide at 20℃;
47%
methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

Tocopherol
59-02-9

Tocopherol

2-(4,8,12-trimethyltridecyl)-2,5,7,8-tetramethyl-chroman-6-ylmethanesulfonate
1261156-27-7

2-(4,8,12-trimethyltridecyl)-2,5,7,8-tetramethyl-chroman-6-ylmethanesulfonate

Conditions
ConditionsYield
Stage #1: Tocopherol With triethylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: methanesulfonyl chloride In dichloromethane for 1h;
96%
With pyridine; dmap In dichloromethane at 20℃; for 24h;85.1%
With pyridine; dmap In dichloromethane at 20℃; for 12h;85.1%
2,3-O-isopropylidene-4-O-benzyl-α-L-rhamnopyranosyl diphenylphosphate

2,3-O-isopropylidene-4-O-benzyl-α-L-rhamnopyranosyl diphenylphosphate

Tocopherol
59-02-9

Tocopherol

C45H70O6

C45H70O6

Conditions
ConditionsYield
With C53H57F11N6O4S2 In di-isopropyl ether at 30℃; for 24h; Molecular sieve; Sealed tube; stereoselective reaction;96%
p-methoxybenzyl chloride
824-94-2

p-methoxybenzyl chloride

Tocopherol
59-02-9

Tocopherol

4-methoxybenzyl (R,R,R)-α-tocopheryl ether
1402580-98-6

4-methoxybenzyl (R,R,R)-α-tocopheryl ether

Conditions
ConditionsYield
Stage #1: Tocopherol With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.333333h;
Stage #2: p-methoxybenzyl chloride With tetra-(n-butyl)ammonium iodide In tetrahydrofuran; mineral oil at 20℃;
95%
2,3:4,6-di-O-isopropylidene-α-D-mannopyranosyl diphenylphosphate

2,3:4,6-di-O-isopropylidene-α-D-mannopyranosyl diphenylphosphate

Tocopherol
59-02-9

Tocopherol

C41H68O7

C41H68O7

Conditions
ConditionsYield
With C53H57F11N6O4S2 In di-isopropyl ether at 50℃; for 24h; Molecular sieve; Sealed tube; stereoselective reaction;95%
5-bromo-3-pyridinecarboxylic acid
20826-04-4

5-bromo-3-pyridinecarboxylic acid

Tocopherol
59-02-9

Tocopherol

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl 5-bromonicotinate

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl 5-bromonicotinate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran Inert atmosphere;95%
succinic acid anhydride
108-30-5

succinic acid anhydride

Tocopherol
59-02-9

Tocopherol

vitamin E succinate
4345-03-3

vitamin E succinate

Conditions
ConditionsYield
With pyridine; dmap at 25℃;94%
With sodium hydroxide In butanone at 40℃; for 6h; Reagent/catalyst; Temperature; Solvent;93.6%
dmap; triethylamine In dichloromethane at 25℃;85%
2-Bromoacetyl bromide
598-21-0

2-Bromoacetyl bromide

Tocopherol
59-02-9

Tocopherol

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl 2-bromoacetate

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl 2-bromoacetate

Conditions
ConditionsYield
With pyridine In dichloromethane at 0℃; for 3h;93.82%
With pyridine In dichloromethane at 0℃; for 3h;93.82%
With pyridine In dichloromethane at 0 - 20℃; Inert atmosphere; Sealed tube;86%
With pyridine In dichloromethane at 20℃; Inert atmosphere;59%
With pyridine In dichloromethane at 0℃; for 3h;1 g
N-benzoyl-N-methyl-4-methylbenzenesulfonamide
10533-83-2

N-benzoyl-N-methyl-4-methylbenzenesulfonamide

Tocopherol
59-02-9

Tocopherol

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl benzoate
102734-34-9

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl benzoate

Conditions
ConditionsYield
With potassium phosphate In tetrahydrofuran at 23℃; for 15h; Inert atmosphere; Schlenk technique;93%
Tocopherol
59-02-9

Tocopherol

2-[(3R,7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dione
7559-04-8

2-[(3R,7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dione

Conditions
ConditionsYield
With bromine In ethanol at 0 - 20℃; for 1.16667h; pH=6; Mechanism; Solvent; Time; Temperature; pH-value; aq. phosphate buffer;92%
With dihydrogen peroxide; methyltrioxorhenium(VII) In ethanol; water at 25℃; for 10h;90%
With iron(III) chloride In methanol; diethyl ether; water for 0.5h;89%

59-02-9Relevant articles and documents

Novel PEGylated derivatives of α-tocopherol for nanocarrier formulations; synthesis, characterization and in vitro cytotoxicity against MCF-7 breast cancer cells

Esmaeelzadeh, Maryam,Mazarei, Zeinab,Rafati, Hasan,Salehi, Peyman,Savadkouhi, Niloofar

supporting information, (2021/03/17)

Despite numerous beneficial therapeutic effects namely antioxidant and anti-inflammatory activity, Vitamin E has limited clinical applications due to its low water solubility. Throughout the present work, α-tocopherol's new PEGylated derivatives alongside with polyethylene glycol 300 (α-TPGT300), 400 (α-TPGT400), and 1000 (α-TPGT1000) were synthesized. A 1,2,3-triazole ring was utilized as a linker for the attachment of alpha tocopherol to the PEGs through a click reaction. The purified derivatives were characterized by the means of 1H NMR, 13C NMR, mass spectroscopy, UV–vis and FT-IR methods. Synthesized derivatives’ capacity to produce self-assembly nanoparticles was evaluated employing the critical micelle concentration (CMC) values. The stability of the micelles was studied by size analysis. In vitro cytotoxicity of the products was investigated using MTT assay against MCF-7 breast cancer cells. The IC50 value for TPGT1000 after 24 h treatment was 15.0 ± 1.8 μM, whereas no significant cytotoxicity effect was observed following the treatment of MCF-7 cells by TPGT300, 400. The present study showed that polymeric micelle TPGT1000 possessed better physicochemical and biological properties including relatively lower CMC value, higher stability in FBS environment in addition to higher cytotoxicity against MCF-7 breast cancer cells compared to the lower molecular weight PEGylated derivatives. These results confirmed that increasing PEG chain length left a positive effect on the polymeric micelle properties and also improved the cytotoxicity effect of new PEGylated vitamin E derivatives.

A mild and practical method for deprotection of aryl methyl/benzyl/allyl ethers with HPPh2andtBuOK

Pan, Wenjing,Li, Chenchen,Zhu, Haoyin,Li, Fangfang,Li, Tao,Zhao, Wanxiang

, p. 7633 - 7640 (2021/09/22)

A general method for the demethylation, debenzylation, and deallylation of aryl ethers using HPPh2andtBuOK is reported. The reaction features mild and metal-free reaction conditions, broad substrate scope, good functional group compatibility, and high chemical selectivity towards aryl ethers over aliphatic structures. Notably, this approach is competent to selectively deprotect the allyl or benzyl group, making it a general and practical method in organic synthesis.

Imidazole ionic liquid, preparation method thereof, and application thereof in synthesis of vitamin E acetate

-

Paragraph 0032-0051, (2019/05/02)

The invention discloses an imidazole ionic liquid, a preparation method thereof, and an application thereof in the synthesis of vitamin E acetate. The structure of the imidazole ionic liquid is represented by formula (I) shown in the description, and Y in the formula (I) is ZnCl2Br or ZnBr. The catalyst has the advantages of cheapness, easiness in obtaining, and stable performances, and has the advantages of good catalytic activity, simple reaction process, mild reaction conditions, high conversion rate and selectivity and no pollution when used in catalytically synthesizing the reaction of vitamin E.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 59-02-9